RBC Capital reiterated coverage on Pennant Gr with a new price target
$PNTG
Medical/Nursing Services
Health Care
RBC Capital reiterated coverage of Pennant Gr with a rating of Outperform and set a new price target of $26.00 from $37.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/19/2024 | $33.00 | Equal Weight | Wells Fargo |
| 1/5/2024 | $14.00 → $18.00 | Equal-Weight → Overweight | Stephens |
| 2/27/2023 | $15.00 → $16.00 | Hold → Buy | Stifel |
| 8/25/2022 | $22.00 | Outperform | Oppenheimer |
| 6/21/2022 | $23.00 → $17.00 | Overweight → Equal-Weight | Stephens |
| 3/10/2022 | $37.00 → $26.00 | Outperform | RBC Capital |
| 3/2/2022 | $33.00 → $26.00 | Overweight | Stephens & Co. |
| 3/1/2022 | $32.00 → $18.00 | Buy → Hold | Stifel |
8-K - Pennant Group, Inc. (0001766400) (Filer)
10-Q - Pennant Group, Inc. (0001766400) (Filer)
8-K - Pennant Group, Inc. (0001766400) (Filer)
4 - Pennant Group, Inc. (0001766400) (Issuer)
4 - Pennant Group, Inc. (0001766400) (Issuer)
4 - Pennant Group, Inc. (0001766400) (Issuer)